Cited by 1,251Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Open access

O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., for the Hypertrophic Cardiomyopathy Outcomes Investigators·2014·European Heart Journal

DOI 10.1093/eurheartj/eht439

Open this paper in CoChat — free account Open PDF

Abstract

AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of this study was to develop and validate a new SCD risk prediction model that provides individualized risk estimates. METHODS AND RESULTS: The prognostic model was derived from a retrospective, multi-centre longitudinal cohort study. The model was developed from the entire data set using the Cox proportional hazards model and internally validated using bootstrapping. The cohort consisted of 3675 consecutive patients from six centres. During a follow-up period of 24 313 patient-years (median 5.7 years), 198 patients (5%) died suddenly or had an appropriate implantable cardioverter defibrillator (ICD) shock. Of eight pre-specified predictors, age, maximal left ventricular wall thickness, left atrial diameter, left ventricular outflow tract gradient, family history of SCD, non-sustained ventricular tachycardia, and unexplained syncope were associated with SCD/appropriate ICD shock at the 15% significance level. These predictors were included in the final model to estimate individual probabilities of SCD at 5 years. The calibration slope was 0.91 (95% CI: 0.74, 1.08), C-index was 0.70 (95% CI: 0.68, 0.72), and D-statistic was 1.07 (95% CI: 0.81, 1.32). For every 16 ICDs implanted in patients with ≥4% 5-year SCD risk, potentially 1 patient will be saved from SCD at 5 years. A second model with the data set split into independent development and validation cohorts had very similar estimates of coefficients and performance when externally validated. CONCLUSION: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/eht439

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Self-citation
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Prognosis and prognostic research: what, why, and how?
Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b375 · Cited by 1,337
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259

Show all 50 references

Research works printed but not linked: 1

2012, Circulation: Arrhythmia and Electrophysiology, 6, 443

Sorted by citations

Items 401–500 of 999

Non-invasive estimation of left ventricular systolic peak pressure: a prerequisite to calculate myocardial work in hypertrophic obstructive cardiomyopathy
Batzner, A., Hahn, P., Morbach, C., Störk, S., Maack, C., Verheyen, N., Gerull, B., Frantz, S., & Seggewiß, H. (2023) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jead236 · Cited by 15
The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre
Paratz, E. D., Stub, D. A., Sutherland, N., Gutman, S., Gerche, A. L., Mariani, J. A., Taylor, A. J., & Ellims, A. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131416 · Cited by 15
Hypertrophic Cardiomyopathy in Underrepresented Populations: Clinical and Genetic Landscape Based on a Russian Single-Center Cohort Study
Сергеевна, Ч. О., Baklanova, T., Milovanova, N. V., & Zateyshchikov, D. A. (2023) · Genes · doi:10.3390/genes14112042 · Cited by 15
The Revolution of Cardiac Myosin Inhibitors in Patients With Hypertrophic Cardiomyopathy
Haraf, R. H., Habib, H., & Masri, A. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.01.022 · Cited by 15
Luces y sombras en el diagnóstico genético de la miocardiopatía hipertrófica
Gómez, J., Reguero, J. R., & Coto, E. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.10.003 · Cited by 15
Sudden Cardiac Death in Genetic Cardiomyopathies
Atteya, G. A., & Lampert, R. J. (2017) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2017.07.009 · Cited by 15
Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death
Smith, E. D., Tome, J., McGrath, R., Kumar, S., Concannon, M., Day, S. M., Saberi, S., & Helms, A. S. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.07.110 · Cited by 15
Current state of the roles of alcohol septal ablation and surgical myectomy in the treatment of hypertrophic obstructive cardiomyopathy
Douglas, J. S. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.07.02 · Cited by 15
Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging
Kitai, T., Xanthopoulos, A. V., Nakagawa, S., Ishii, N., Amano, M., Triposkiadis, F. K., & Izumi, C. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9060169 · Cited by 15
Prediction of Sudden Cardiac Arrest After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: ASA-SCARRE Risk Score
Veselka, J., Liebregts, M., Cooper, R. M., Faber, L., Januška, J., Kashtanov, M. G., Tesárková, K. H., Hansen, P. R., Seggewiß, H., Shloydo, E., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.08.028 · Cited by 15
Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy
Özyılmaz, S. (2017) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.7593 · Cited by 15
Galectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Emet, S., Dadashov, M., Sonsöz, M. R., Çakır, M. O., Yılmaz, M., Elitok, A., Bilge, A. K., Mercanoğlu, F., Öncül, A., Adalet, K., et al. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.08.013 · Cited by 15
Alcohol septal ablation in patients with severe septal hypertrophy
Veselka, J., Jensen, M. K., Liebregts, M., Cooper, R. M., Januška, J., Kashtanov, M. G., Dąbrowski, M., Hansen, P. R., Seggewiß, H., Hansvenclová, E., et al. (2019) · Heart · doi:10.1136/heartjnl-2019-315422 · Cited by 15
Mechanisms of Arrhythmogenicity in Hypertrophic Cardiomyopathy: Insight From Non-invasive Electrocardiographic Imaging
Alday, E. A. P., Haq, K. T., German, D. M., Hamilton, C., Johnson, K., Phan, F. T., Rogovoy, N. M., Yang, K. Y., Wirth, A., Thomas, J., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00344 · Cited by 14
Relationship between life-threatening events and electromechanical window in patients with hypertrophic cardiomyopathy: A novel parameter for risk stratification of sudden cardiac death
Song, M. K., Baek, S.-M., Kim, G. B., Lee, S. Y., Kwon, H. W., Lee, H., Choi, Y., Kim, H., & Bae, E. J. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.12.016 · Cited by 14
The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
Karabinowska-Małocha, A., Dziewięcka, E. M., Banyś, P., Urbańczyk‐Zawadzka, M., Krupiński, M., Mielnik, M., Łach, J., Budkiewicz, A., Podolec, P. S., Żydzik, Ł., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020294 · Cited by 14
Deep-Risk: Deep Learning-Based Mortality Risk Predictive Models for COVID-19
Elshennawy, N. M., Ibrahim, D. M., Sarhan, A. M., & Arafa, M. M. (2022) · Diagnostics · doi:10.3390/diagnostics12081847 · Cited by 18
Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling
Shimada, Y. J., Raita, Y., Liang, L. W., Maurer, M. S., Hasegawa, K., Fifer, M. A., & Reilly, M. P. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003546 · Cited by 14
Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy
Kaski, J. P., Kammeraad, J. A. E., Blom, N. A., Happonen, J.-M., Janoušek, J., Klaassen, S., Limongelli, G., Östman‐Smith, I., Sarquella‐Brugada, G., & Ziółkowska, L. (2023) · Cardiology in the Young · doi:10.1017/s1047951123000872 · Cited by 14
Self-citation
Genetic Evaluation and Screening in Cardiomyopathies: Opportunities and Challenges for Personalized Medicine
Aiyer, S., Kalutskaya, E., Agdamag, A. C., & Tang, W. H. W. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13060887 · Cited by 16
Risk Stratification for Sudden Cardiac Death in Repaired Tetralogy of Fallot
Kakarla, J., Denham, N. C., Ishikita, A., Oechslin, E. N., Alonso-González, R., & Nair, K. (2023) · CJC Pediatric and Congenital Heart Disease · doi:10.1016/j.cjcpc.2023.07.002 · Cited by 14
Development and Validation of Machine Learning–Based Models to Predict In-Hospital Mortality in Life-Threatening Ventricular Arrhythmias: Retrospective Cohort Study
Li, L., Ding, L., Zhang, Z., Zhou, L., Zhang, Z., Xiong, Y., Hu, Z., & Yao, Y. (2023) · Journal of Medical Internet Research · doi:10.2196/47664 · Cited by 14
Midterm Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy: A Single‐Center, Observational Study
Xie, X., Chen, S., Cui, Y., Zhou, Z., Lü, J., Du, Z. J., Ding, J., Xing, K., Zhang, Y., Zhou, Y., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034080 · Cited by 14
Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy
Amano, M., Kitaoka, H., Yoshikawa, Y., Sakata, Y., Dohi, K., Tokita, Y., Kato, T., Matsushima, S., Kitai, T., Okada, A., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2024.12.006 · Cited by 14
Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery
Magnusson, P., Gadler, F., Liv, P., & Mörner, S. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12750 · Cited by 14
Survival and Clinical Behavior of Hypertrophic Cardiomyopathy in a Latin American Cohort in Contrast to Cohorts from the Developed World
Espinola-Zavaleta, N. G., Vega, A., Basto, D. M., Alcantar-Fernández, A. C., Guarner‐Lans, V., & Soto, M. E. (2015) · Journal of Cardiovascular Ultrasound · doi:10.4250/jcu.2015.23.1.20 · Cited by 14
ESC sudden‐death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast‐enhanced CMR in intermediate‐risk patients
Hinojar, R., Zamorano, J. L., Gómez, A. G., Martín, M. P., Esteban, A., Rincon, L. M., Portugal, J. C., Nácher, J. J. J., & Fernández‐Golfín, C. (2017) · Clinical Cardiology · doi:10.1002/clc.22735 · Cited by 14
Risk stratification in hypertrophic cardiomyopathy
Marrakchi, S., Kammoun, I., Bennour, E., Laroussi, L., & Kachboura, S. (2018) · Herz · doi:10.1007/s00059-018-4700-8 · Cited by 14
Hypertrophic cardiomyopathy in children
Wang, S., & Zhu, C. (2021) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/02184923211041285 · Cited by 14
Strategies for Sudden Cardiac Death Prevention
Corianò, M., & Tona, F. (2022) · Biomedicines · doi:10.3390/biomedicines10030639 · Cited by 15
Insights Into Hypertrophic Cardiomyopathy Evaluation Through Follow-up of a Founder Pathogenic Variant
Lorca, R., Gómez, J., Martı́n, M., Cabanillas, R., Calvo, J., León, V., Pascual, I., Morı́s, C., Coto, E., & Reguero, J. J. R. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.02.009 · Cited by 14
Age-Related Survival After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Batzner, A., Aicha, D., Pfeiffer, B., Neugebauer, A., & Seggewiß, H. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13750 · Cited by 14
Further Refining Risk in Hypertrophic Cardiomyopathy With Late Gadolinium Enhancement by CMR
Kramer, C. M., & Neubauer, S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.063 · Cited by 14
Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience
Steinberg, C., Nadeau‐Routhier, C., André, P., Philippon, F., SARRAZIN, J., Nault, I., O’Hara, G. E., Blier, L. E., Molin, F., Plourde, B., et al. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.548564 · Cited by 13
The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy
Yu, T., Cai, Z., Yang, Z., Lin, W., Su, Y. A., Li, J., Xie, S., & Shen, J. (2023) · Academic Radiology · doi:10.1016/j.acra.2022.12.026 · Cited by 14
Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making
Norrish, G., Protonotarios, A., Stec, M., Boleti, O., Field, E., Cervi, E., Elliot, P. M., & Kaski, J. P. (2023) · EP Europace · doi:10.1093/europace/euad330 · Cited by 13
Comparative prognostic importance of measures of left atrial structure and function in non-ischaemic dilated cardiomyopathy
Hammersley, D. J., Mukhopadhyay, S., Chen, X., Cheng, L., Jones, R. E., Mach, L., Curran, L., Yazdani, M. F., Iacob, A. O., Lota, A. S., et al. (2024) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeae080 · Cited by 13
Implantable cardioverter defibrillator therapy in paediatric patients for primary vs. secondary prevention
Thuraiaiyah, J., Philbert, B. T., Jensen, A. S., Xing, L. Y., Jørgensen, T. H., Lim, C. W., Jakobsen, F. N., Bække, P. S., Schmidt, M. R., Idorn, L., et al. (2024) · EP Europace · doi:10.1093/europace/euae245 · Cited by 13
Hypertrophic Cardiomyopathy in Liver Transplantation Patients
Pai, S., Aniskevich, S., Logvinov, I. I., Matcha, G. V., Palmer, W. C., & Blackshear, J. L. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2018.02.080 · Cited by 13
Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy
Rigopoulos, A. G., Ali, M. N. L., Abate, E., Matiakis, M., Melnyk, H., Mavrogeni, S. I., Leftheriotis, D. I., Bigalke, B., & Noutsias, M. (2019) · Heart Failure Reviews · doi:10.1007/s10741-018-09767-w · Cited by 13
The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp‐e interval, 5‐year sudden cardiac death risk score in hypertrophic cardiomyopathy patients
Demir, A. R., Çelik, Ö., Sevinç, S., Uygur, B., Kahraman, S., Yılmaz, E., Cemek, M., Önal, Y., & Ertürk, M. (2019) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12672 · Cited by 13
Cardiomyopathies in children: classification, diagnosis and treatment
Angelis, G. D., Bobbo, M., Paldino, A., Mottolese, B. D., Altinier, A., Ferro, M. D., Merlo, M., & Sinagra, G. (2020) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000755 · Cited by 13
Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy: The Utility of Myocardial Strain Based on Cardiac MR Tissue Tracking
She, J., Guo, J., Yu, Y., Zhao, S., Chen, Y., Ge, M., Zeng, M., & Jin, H. M. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27307 · Cited by 13
Risk of arrhythmic events after alcohol septal ablation for hypertrophic cardiomyopathy using continuous implantable cardiac monitoring
Bleszynski, P. A., Goldenberg, I., Fernandez, G., Howell, E. H., Younis, A., Chen, A. Y., McNitt, S. A., Bruckel, J., Ling, F. S., Cove, C. J., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.08.013 · Cited by 13
Novel Hypertrophic Cardiomyopathy Diagnosis Index Using Deep Features and Local Directional Pattern Techniques
Gudigar, A., Raghavendra, U., Samanth, J., Dharmik, C., Gangavarapu, M. R., Nayak, K., Ciaccio, E. J., Tan, R., Molinari, F., & Acharya, U. R. (2022) · Journal of Imaging · doi:10.3390/jimaging8040102 · Cited by 13
Should lethal arrhythmias in hypertrophic cardiomyopathy be predicted using non-electrophysiological methods?
Saumarez, R. C., Silberbauer, J., Scannell, J. W., Pytkowski, M., Behr, E. R., Betts, T. R., Bella, P. E. D., & Peters, N. S. (2023) · EP Europace · doi:10.1093/europace/euad045 · Cited by 13
Update on the Diagnosis and Management of Hypertrophic Cardiomyopathy
Semsarian, C. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.10.007 · Cited by 13
Prognostic value of electrocardiographic time intervals and QT rate dependence in hypertrophic cardiomyopathy
Robyns, T., Nuyens, D., Lu, H. R., Gallacher, D. J., Vandenberk, B., Garweg, C., Ector, J., Pagourelias, E. D., Cleemput, J. V., Janssens, S. P., et al. (2018) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2018.09.005 · Cited by 13
Assessing the risk of early unplanned rehospitalisation in preterm babies: EPIPAGE 2 study
Reed, R. A., Morgan, A. S., Zeitlin, J. A., Jarreau, P., Torchin, H., Pierrat, V., Ancel, P., & Khoshnood, B. (2019) · BMC Pediatrics · doi:10.1186/s12887-019-1827-6 · Cited by 13
Cardiac Magnetic Resonance Imaging Features in Hypertrophic Cardiomyopathy Diagnosed at <21 Years of Age
Bonura, E. D., Bos, J. M., Abdelsalam, M. A., Araoz, P. A., Ommen, S. R., Ackerman, M. J., & Geske, J. B. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.01.027 · Cited by 13
Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification
Stafford, F., Thomson, K. L., Butters, A., & Ingles, J. (2021) · Current Cardiology Reports · doi:10.1007/s11886-020-01437-4 · Cited by 13
Outcomes of Septal Myectomy beyond 65 Years, with and without Concomitant Procedures
Pruna‐Guillen, R., Pereda, D., Castellà, M., Sandoval, E., Affronti, A., García‐Álvarez, A., Perdomo, J. M., Ibáñez, C., Jordà, P., Prat, S., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163499 · Cited by 13
Cardiac Magnetic Resonance Imaging and Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
McKenna, W. J., & Nagueh, S. F. (2014) · Circulation · doi:10.1161/circulationaha.114.010977 · Cited by 13
Self-citation
Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy
Theuns, D. A. M. J., Verstraelen, T. E., van der Lingen, A. C. J., Delnoy, P. P. H. M., Allaart, C. P., ERVEN, L. V., Maass, A. H., Vernooy, K., Wilde, A. A. M., Boersma, E. H., et al. (2022) · Netherlands Heart Journal · doi:10.1007/s12471-022-01718-3 · Cited by 12
Canadian Cardiovascular Society Clinical Practice Update on Contemporary Management of the Patient With Hypertrophic Cardiomyopathy
Crean, A. M., Adler, A., Arbour, L. T., Chan, J., Christian, S., Cooper, R. M., Garceau, P., Giraldeau, G., Heydari, B., Laksman, Z., et al. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.06.007 · Cited by 12
Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals
Schoonvelde, S. A. C., Alexandridis, G. M., Price, L. B., Schinkel, A. F. L., Hirsch, A., Zwetsloot, P.-P. M., Kammeraad, J. A. E., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132951 · Cited by 11
Integrative Approaches in the Management of Hypertrophic Cardiomyopathy: A Comprehensive Review of Current Therapeutic Modalities
Dicorato, M. M., Citarelli, G., Mangini, F., Alemanni, R., Albanese, M., Cicco, S., Greco, C. A., Forleo, C., Basile, P., Carella, M. C., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13051256 · Cited by 13
Biatrial performance in children with hypertrophic cardiomyopathy: CMR study
Mazurkiewicz, Ł., Ziółkowska, L., Petryka, J., Śpiewak, M., Małek, Ł. A., Kubik, A., Marczak, M., Miśko, J., & Brzezińska‐Rajszys, G. (2018) · European Radiology · doi:10.1007/s00330-018-5519-7 · Cited by 12
Impaired repolarization parameters may predict fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy (from the CILICIA Registry)
Güner, A., Kalçık, M., Çelık, M., Uzun, F., Çizgici, A. Y., Ağuş, H. Z., Aslan, S., Güner, E. G., Ulutaş, A. E., Bayam, E. M., et al. (2020) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2020.10.009 · Cited by 12
Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases
Volpato, G., Falanga, U., Cipolletta, L., Conti, M. A., Grifoni, G., Ciliberti, G., Urbinati, A., Barbarossa, A., Stronati, G., Fogante, M., et al. (2021) · Medicina · doi:10.3390/medicina57040308 · Cited by 15
Machine learning
SCHNEIDER, P. L., & Xhafa, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823818-9.00019-5 · Cited by 17
Miocardiopatía hipertrófica
Mateo, J. J. S., Molina, M. S., & Gimeno, J. R. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.09.013 · Cited by 12
Self-citation
Recent advances in hypertrophic cardiomyopathy
Yingchoncharoen, T., & Tang, W. H. W. (2014) · F1000Prime Reports · doi:10.12703/p6-12 · Cited by 12
Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy
Magnusson, P., Gadler, F., Liv, P., & Mörner, S. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12801 · Cited by 12
Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications
Viliani, D., Pozo, E., Aguirre, N., Cecconi, A., Olivera, M. J., Caballero, P., Jiménez‐Borreguero, L. J., & Alfonso, F. (2017) · International journal of cardiac imaging · doi:10.1007/s10554-017-1161-8 · Cited by 12
Mort subite de l’adulte : une meilleure compréhension pour une meilleure prévention
Waldmann, V., Bougouin, W., Karam, N., Albuisson, J., Cariou, A., Jouven, X., & Marijon, É. (2017) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2017.06.002 · Cited by 12
Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
Lyon, A., Mincholé, A., Bueno‐Orovio, A., & Rodríguez, B. (2019) · Morphologie · doi:10.1016/j.morpho.2019.09.001 · Cited by 12
Advances in hypertrophic cardiomyopathy: What the cardiologist needs to know
Toste, A. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.05.015 · Cited by 12
2025 Clinical practice guidelines for Ventricular arrhythmias of the heart and Sudden cardiac death
Mikhailov, E. N., Gizatulina, T. P., Lebedev, D. S., Golukhova, E. Z., Kharlap, M. S., Лебедева, В. К., Bagnenko, S. F., Artyukhina, Е. А., Babokin, V. E., Batalov, R. E., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6670 · Cited by 14
Advances in Multi-Modality Imaging in Hypertrophic Cardiomyopathy
Goldie, F. C., Lee, M. M. Y., COATS, C. J., & Nordin, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030842 · Cited by 11
Exploring Health Care Disparities in Genetic Testing and Research for Hereditary Cardiomyopathy: Current State and Future Perspectives
Huang, H., Verma, J., Mok, V., Bharadwaj, H. R., Alrawashdeh, M. M., Aratikatla, A., Sudan, S., Talukder, S., Habaka, M., Tse, G., et al. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1779469 · Cited by 15
Feasibility of remote monitoring for fatal coronary heart disease using Apple Watch ECGs
Butler, L., Ivanov, A., Celık, T., Karabayir, İ., Chinthala, L. K., Hudson, M. M., Ness, K. K., Mulrooney, D. A., Dixon, S. B., Tootooni, M. S., et al. (2024) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2024.03.007 · Cited by 11
Cardiomyopathy and Sudden Cardiac Death: Bridging Clinical Practice with Cutting-Edge Research
Mistrulli, R., Ferrera, A., Salerno, L., Vannini, F., Guida, L., Corradetti, S., Addeo, L., Valcher, S., Gioia, G. D., Spera, F. R., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071602 · Cited by 11
Clinical Course and Treatment of Patients With Apical Aneurysms Due to Hypertrophic Cardiomyopathy
Sherrid, M. V., Massera, D., Bernard, S., Tripathi, N., Patel, Y. R., Modi, V. A., Axel, L., Talebi, S., Sarić, M., Adlestein, E., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101195 · Cited by 11
Extended ambulatory ECG monitoring enhances identification of higher-risk ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy
Rowin, E. J., Das, G., Madias, C. A., Hsu, M., Crosson, L. A., Turakhia, M. P., Maron, B. J., & Maron, M. S. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.09.040 · Cited by 12
Diagnosis and management of hypertrophic cardiomyopathy: European vs. American guidelines
Aimo, A., Todiere, G., Barison, A., Tomasoni, D., Panichella, G., Masri, A., & Maron, M. S. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10464-0 · Cited by 11
Factors associated with high-intensity physical activity and sudden cardiac death in hypertrophic cardiomyopathy
Lee, H., Gwak, S., Kim, K., Cho, I., Shim, C. Y., Ha, J., & Hong, G. (2025) · Heart · doi:10.1136/heartjnl-2024-324928 · Cited by 11
Non-invasive detection of exercise-induced cardiac conduction abnormalities in sudden cardiac death survivors in the inherited cardiac conditions
Leong, K. M. W., Ng, F. S., Shun-Shin, M. J., Koa‐Wing, M., Qureshi, N. A., Whinnett, Z. I., Linton, N. F., Lefroy, D. C., Francis, D. P., Harding, S. E., et al. (2020) · EP Europace · doi:10.1093/europace/euaa248 · Cited by 11
Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
Du, D., Li, C. O. Y., Ong, K., Parsa, A., Weissler‐Snir, A., Geske, J. B., & Laksman, Z. (2022) · CJC Open · doi:10.1016/j.cjco.2022.01.001 · Cited by 11
Predicting Left Ventricular Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy by Speckle Tracking Automated Functional Imaging
Hu, X., Bao, Y., Zhu, Y. Y., Zheng, K., Zhang, J., Zhou, W., Deng, Y., & Liu, Y. (2023) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2023.01.020 · Cited by 11
Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis
Ashkir, Z., Johnson, S., Lewandowski, A. J., Hess, A. T., Wicks, E. C., Mahmod, M., Myerson, S. G., Ebbers, T., Watkins, H. C., Neubauer, S., et al. (2023) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jead074 · Cited by 11
Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy
Konstantinou, D. M., Efthimiadis, G. K., Vassilikos, V. P., Paraskevaidis, S., Pagourelias, E. D., Maron, B. J., & Karvounis, H. I. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000333 · Cited by 11
Entendimiento de la miocardiopatía hipertrófica mediante el estudio de una variante patogénica fundadora
Lorca, R., Gómez, J., Martı́n, M., Cabanillas, R., Calvo, J., León, V., Pascual, I., Morı́s, C., Coto, E., & Reguero, J. J. R. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.01.029 · Cited by 11
Incorporating patients’ preference diagnosis in implantable cardioverter defibrillator decision-making
Lewis, K. B., Carroll, S. L., Birnie, D. H., Stacey, D., & Matlock, D. D. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000464 · Cited by 11
Prognostic value of the 12-lead surface electrocardiogram in sarcomeric hypertrophic cardiomyopathy: data from the REMY French register
Ledieu, N., Larnier, L., Auffret, V., Marie, C., Fargeau, D., Donal, E., Mirabel, M., Jeunemaı̂tre, X., Puscas, T., Marijon, É., et al. (2019) · EP Europace · doi:10.1093/europace/euz272 · Cited by 11
Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults
Magnusson, P., & Wimo, A. B. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.02.055 · Cited by 11
Association Between Depression and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
Hu, H., Chen, H., Zhu, C., Yue, X., Wang, H., Qian, G., Zhai, C., & He, C. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019071 · Cited by 11
New approaches to predicting the risk of sudden death
Behr, E. R., & Ensam, B. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-3-283 · Cited by 9
Dynamic obstruction in hypertrophic cardiomyopathy
Popescu, B. A., Roşca, M., & Schwammenthal, E. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000199 · Cited by 11
Septal myectomy after failed septal alcohol ablation
Quintana, E., Bajona, P., Arguis, M. J., & Prat, S. (2017) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2017.05.11 · Cited by 11
Detection of Myocardial Tissue Alterations in Hypertrophic Cardiomyopathy Using Texture Analysis of T2-Weighted Short Inversion Time Inversion Recovery Magnetic Resonance Imaging
Amano, Y., Yanagisawa, F., Omori, Y., Suzuki, Y., Ando, C., Yamamoto, H., & Matsumoto, N. (2020) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001007 · Cited by 11
Risk Stratification and Hypertrophic Cardiomyopathy Subtypes
Sherrid, M. V., & Massera, D. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.020 · Cited by 11
Inflammation and Immunogenetics in Cardiomyopathies: From Molecular Mechanisms to Therapeutic Perspectives
Peretto, G., Villatore, A., & Cooper, L. T. (2026) · Immunological Reviews · doi:10.1111/imr.70105 · Cited by 10
Renal function as a predictor of outcomes in patients with hypertrophic cardiomyopathy: A cohort study of a hospitalized population
Huang, F., Zhang, J., Huang, B., Peng, Y., Chen, S.-J., & Chen, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.11.022 · Cited by 10
Usefulness of Longitudinal Strain Adjusted to Regional Thickness in Hypertrophic Cardiomyopathy
Urtado, S., Hergault, H., Binsse, S., Aïdan, V., Ouadahi, M., Szymanski, C., Mallet, S., Hauguel‐Moreau, M., Carlier, R., Dubourg, O., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082089 · Cited by 11
Sudden cardiac death in childhood hypertrophic cardiomyopathy
Thakkar, K., Karajgi, A. R., Kallamvalappil, A. M., Avanthika, C., Jhaveri, S., Shandilya, A., Anusheel, & Al-masri, R. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101548 · Cited by 10
Guía de práctica clínica de la ESC 2014 sobre el diagnóstico y manejo de la miocardiopatía hipertrófica
Elliot, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagège, A. A., Lafont, A. M., Limongelli, G., Mahrholdt, H., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.12.001 · Cited by 10
Self-citation
Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells
Liang, W., Gasparyan, L., Alqarawi, W., & Davis, D. R. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1575359 · Cited by 9
Hypertrophic Cardiomyopathy: Challenging the Status Quo?
Younger, J. F., Lo, A., McCormack, L., McGaughran, J. M., Prasad, S. B., & Atherton, J. J. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.12.005 · Cited by 10
The SHIFT model combines clinical, electrocardiographic and echocardiographic parameters to predict sudden cardiac death in hypertrophic cardiomyopathy
Ruivo, C., Sá, F. M., Correia, J., Belo, A., Loureiro, M. F., & Morais, J. (2019) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2019.05.012 · Cited by 10

Authors: O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., & for the Hypertrophic Cardiomyopathy Outcomes Investigators
Affiliations: University College London (GB)
National and Kapodistrian University of Athens (GR)
University of Bologna (IT)
Hospital Universitario Virgen de la Arrixaca (ES)
University of Campania "Luigi Vanvitelli" (IT)
University College Hospital at Westmoreland Street (GB)
ORCID: Pavlou, M.
Monserrat, L.
Rapezzi, C.
Biagini, E.
Gimeno, J. R.
Limongelli, G.
McKenna, W. J.
Omar, R. Z.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2013-10-14
Volume: 35
Issue: 30
Pages: 2010-2020
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/eht439
OpenAlex: W2119361626
Cited by: 1,251
References: 50
Citations by year: 2026: 107 · 2025: 124 · 2024: 115 · 2023: 120 · 2022: 99 · 2021: 125 · 2020: 116 · 2019: 87 · 2018: 81 · 2017: 100 · 2016: 67 · 2015: 76 · 2014: 31 · 2013: 2
FWCI: 39.92
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Hispana (submittedVersion)
Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Funders: National Institute for Health and Care Research (NF-SI-0509-10230)
Università di Bologna
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, sudden cardiac death, risk prediction model, individualized risk estimation, implantable cardioverter-defibrillator, left ventricular wall thickness, left ventricular outflow tract gradient, family history of sudden cardiac death, non-sustained ventricular tachycardia, unexplained syncope, left atrial diameter, model validation
MeSH terms: Adult, Cardiomyopathy, Hypertrophic, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Reproducibility of Results, Proportional Hazards Models, Death, Sudden, Cardiac, Sample Size, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks